tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ENTX Stock Latest News

Entera Bio reports Phase 1 data of oral PTH peptide candidate at ENDO 2024
The FlyEntera Bio reports Phase 1 data of oral PTH peptide candidate at ENDO 2024
1M ago
ENTX
Entera Bio appoints Wagman as Key Clinical Advisor, SAB member
PremiumThe Fly
Entera Bio appoints Wagman as Key Clinical Advisor, SAB member
2M ago
ENTX
Entera Bio to present Phase 1 data from EB612 at ENDO 2024
PremiumThe Fly
Entera Bio to present Phase 1 data from EB612 at ENDO 2024
2M ago
ENTX
Entera Bio to Present Phase 1 Data from First-in-Class, PTH(1-34) Peptide Tablets (EB612) for the Treatment of Hypoparathyroidism at ENDO 2024
PremiumPress Releases
Entera Bio to Present Phase 1 Data from First-in-Class, PTH(1-34) Peptide Tablets (EB612) for the Treatment of Hypoparathyroidism at ENDO 2024
2M ago
ENTX
Entera Bio Releases Crucial Financial Information Update
PremiumCompany Announcements
Entera Bio Releases Crucial Financial Information Update
2M ago
8K
ENTX
Entera Bio Reports Q1 2024 Financial Results and Provides Business Updates
PremiumPress ReleasesEntera Bio Reports Q1 2024 Financial Results and Provides Business Updates
2M ago
ENTX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
OCX
AGEN
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
ADIL
ALPN
Entera Bio publishes data on oral PTH peptide tablet for osteoporosis in JBMR
PremiumThe Fly
Entera Bio publishes data on oral PTH peptide tablet for osteoporosis in JBMR
3M ago
ENTX
Entera Bio Announces Publication of Oral PTH(1-34) Peptide Tablets (EB613) Phase 2 Trial Data in the Journal of Bone and Mineral Research
PremiumPress Releases
Entera Bio Announces Publication of Oral PTH(1-34) Peptide Tablets (EB613) Phase 2 Trial Data in the Journal of Bone and Mineral Research
3M ago
ENTX
Entera Bio announces key milestone for Oral PTH1-34 peptide
PremiumThe Fly
Entera Bio announces key milestone for Oral PTH1-34 peptide
3M ago
ENTX
Entera Bio Announces Key Regulatory Milestone for Oral PTH(1-34) Peptide (EB613) Phase 3 Program: FDA Ruling on Qualifying BMD as a Surrogate Endpoint for Osteoporosis Drugs is Expected Within 10 Months
PremiumPress Releases
Entera Bio Announces Key Regulatory Milestone for Oral PTH(1-34) Peptide (EB613) Phase 3 Program: FDA Ruling on Qualifying BMD as a Surrogate Endpoint for Osteoporosis Drugs is Expected Within 10 Months
3M ago
ENTX
Entera Bio announces PK data from oral GLP-2 peptide tablet treatment
PremiumThe FlyEntera Bio announces PK data from oral GLP-2 peptide tablet treatment
4M ago
OPK
ENTX
Entera Bio management to meet virtually with Oppenheimer
PremiumThe Fly
Entera Bio management to meet virtually with Oppenheimer
4M ago
ENTX
Entera Bio management to meet virtually with Oppenheimer
PremiumThe Fly
Entera Bio management to meet virtually with Oppenheimer
4M ago
ENTX
Entera Bio management to meet virtually with Oppenheimer
PremiumThe Fly
Entera Bio management to meet virtually with Oppenheimer
4M ago
ENTX
Entera Bio management to meet with Oppenheimer
PremiumThe Fly
Entera Bio management to meet with Oppenheimer
4M ago
ENTX
Entera Bio Ltd Shares Financial Update for Investor Awareness
PremiumCompany Announcements
Entera Bio Ltd Shares Financial Update for Investor Awareness
4M ago
8K
ENTX
Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates
PremiumPress Releases
Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates
4M ago
ENTX
Entera Bio management to meet with Oppenheimer
PremiumThe FlyEntera Bio management to meet with Oppenheimer
4M ago
ENTX
Entera Bio management to meet with Oppenheimer
PremiumThe Fly
Entera Bio management to meet with Oppenheimer
4M ago
ENTX
Entera Bio management to meet with Oppenheimer
PremiumThe Fly
Entera Bio management to meet with Oppenheimer
4M ago
ENTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >